Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
14.51
0.38 (2.69%)
At close: Aug 15, 2025, 3:59 PM
14.52
0.10%
After-hours: Aug 15, 2025, 04:20 PM EDT
Mineralys Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -43.27M | -42.21M | -48.95M | -56.34M | -41.01M | -31.51M | -24.39M | -22.76M | -12.14M | -12.61M | -9.07M | -6.68M | -6.48M | -7.57M | -7.08M |
Depreciation & Amortization | 16K | 15K | 15K | 11K | 9K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 4.55M | 3.65M | 3.13M | 6.01M | 2.87K | 2.19M | 1.46M | 1.58M | 1.28M | 749K | 218K | 192K | 26K | 19K | 16K |
Other Working Capital | n/a | -4.34M | -19.71M | 5.7M | 10.65M | 12.68M | -3.98M | 4.11M | -7.54M | -61K | -921K | -263K | 984K | 108.00 | 157.00 |
Other Non-Cash Items | 8.54M | -1.05M | -1.34M | 23.65M | 22.13K | -2.51M | -2.07M | -1.96M | -1.98M | -855K | -410K | -239K | 1.03K | 864.00 | 2.02K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -5.89M | -19.71M | -23.51M | 10.83M | 12.68M | -3.98M | 4.11M | -7.54M | -61K | -921K | -263K | 984K | 972K | 2.18M |
Operating Cash Flow | -30.17M | -45.49M | -66.84M | -50.19M | -30.15M | -19.14M | -28.98M | -19.03M | -20.39M | -12.78M | -10.19M | -6.99M | -5.47M | -6.58M | -4.89M |
Capital Expenditures | n/a | n/a | n/a | -37K | n/a | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -117.88M | -127.88M | -63.93M | -58.86M | -127.26M | -123.39M | -73.09M | -55.99M | -56.14M | -162.75M | n/a | -71.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | 75M | 35M | 147.5M | 138.5M | 135M | 67.5M | 65M | 60M | 40M | 22.5M | 50M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.14K | n/a | 50M | -71.76K | n/a | n/a | n/a |
Investing Cash Flow | -42.88M | -92.88M | 83.57M | 79.61M | 7.74M | -55.95M | -8.09M | 4.01M | -16.14M | -140.25M | 50M | -71.76M | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 142K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.83M | 113K | 116.15M | n/a | -92K | 86K | n/a | n/a | n/a | n/a | -1.07M | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9.83M | 189.28M | 90K | -1K | -152K | 116.2M | 74K | 184K | -581K | 203.57M | -1.07M | -561K | 117.65M | 12M | n/a |
Net Cash Flow | -63.22M | 50.92M | 16.82M | 29.42M | -22.56M | 41.11M | -37M | -14.84M | -37.11M | 50.55M | 38.75M | -79.31M | 112.18M | 5.42M | -4.89M |
Free Cash Flow | -30.17M | -45.49M | -66.84M | -50.22M | -30.15M | -19.2M | -28.98M | -19.03M | -20.39M | -12.78M | -10.19M | -6.99M | -5.47M | -6.58M | -4.89M |